However, in acute myeloid leukemia, a unique CD8+ T cell subset that expressed PD-1 and TIGIT but displayed lower levels of DNAM-1 has been linked to failure to achieve remission after induction chemotherapy. This evidence concerns the gene CD8A and acute myeloid leukemia.